Time-dependent estimates of recurrence and survival in colon cancer: Clinical decision support system tool development for adjuvant therapy and oncological outcome assessment

American Surgeon

Volumn 80, Issue 5, 2014, Pages 441-453

  Steele, Scott R ^a,b,h   Bilchik, Anton ^b,f,g,k   Johnson, Eric K ^a,b,h   Nissan, Aviram ^b,e,k   Peoples, George E ^a,b,i   Berhardt, John S ^d   Kalina, Philip ^d   Petersen, Benjamin ^d   Brücher, Björn ^b,j,k   Protic, Mladjan ^b,k,l,m   Avital, Itzhak ^a,b,j,k   Stojadinovic, Alexander ^a,b,c,k  

^a Uniformed Services University of the Health Sciences   (United States)

^b US Military Cancer Institute   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d DecisionQ Corporation   (United States)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^f JOHN WAYNE CANCER INSTITUTE   (United States)

^g California Oncology Research Institute   (United States)

^h MADIGAN ARMY MEDICAL CENTER   (United States)

ⁱ BROOKE ARMY MEDICAL CENTER   (United States)

^j Virginia Health System   (United States)

^k International Consortium of Research Excellence   (Germany)

^l Clinic of Abdominal   (Serbia)

^m UNIVERSITY OF NOVI SAD   (Serbia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ALGORITHM; AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; FEMALE; HIGH RISK PATIENT; HUMAN; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; TREATMENT PLANNING; VALIDATION PROCESS; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; COLON RESECTION; COLON TUMOR; EVALUATION STUDY; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; STATISTICAL MODEL; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTINEOPLASTIC AGENTS; BAYES THEOREM; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; REGISTRIES; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904547323     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. American Cancer Society Colon Cancer Statistics. Available at: www5.cancer.org/downloads/STT/Cancer-Facts-and-Figures-2010.pdf Accessed January 13, 2013.
2. Romanus D, Weiser MR, Skibber JM, et al. Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis. J Natl Compr Canc Netw 2009;7:895-904.
3. Søreide K, Traeland JH, Stokkeland PJ, et al. Adherence to national guidelines for surveillance after curative resection of nonmetastatic colon and rectum cancer: a survey among Norwegian gastrointestinal surgeons. Colorectal Dis 2012;14:320-4.
4. Mostafa G, Matthews BD, Norton HJ, et al. Influence of demographics on colorectal cancer. Am Surg 2004;70:259-64.
5. O'Malley AS, Forrest CB, Feng S, et al. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med 2005;165:2129-35.
6. Brounts LR, Lehmann RK, Lesperance KE, et al. Improved rates of colorectal cancer screening in an equal access population. Am J Surg 2009;197:609-12.
7. Hassan MO, Arthurs Z, Sohn VY, et al. Race does not impact colorectal cancer treatment or outcomes with equal access. Am J Surg 2009;197:485-90.
8. Young JM, Leong DC, Armstrong K, et al. Concordance with national guidelines for colorectal cancer care in New South Wales: a population-based patterns of care study. Med J Aust 2007;186:292-5.
9. Kuhry E, Schwenk WF, Gaupset R, et al. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev 2008;2:CD003432.
10. Sharif S, O'Connell MJ, Yothers G, et al. FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer. Cancer Invest 2008;26:956-63.
11. Stojadinovic A, Bilchik A, Smith D, et al. Clinical decision support and individualized prediction of survival in colon cancer: Bayesian Belief Network model. Ann Surg Oncol 2013;20:161-74.
12. Commission on Cancer, Facility Oncology Registry Data Standards Revised for 2010. Chicago, IL: American College of Surgeons; May 1, 2010.
13. Commission on Cancer. Volume II: Registry Operations and Data Standards. Chicago, IL: American College of Surgeons; 1998.
14. Zhu K, Devesa SS, Wu H, et al. Cancer incidence in the U.S. military population: comparison with rates from the SEER program. Cancer Epidemiol Biomarkers Prev 2009;18:1740-5.
15. Jatoi I, Becher H, Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system. Cancer 2003;98:894-9.
16. th ed. New York, NY: Springer-Verlag; 2002.
17. He Y, Zaslavsky AM, Landrum MB, et al. Multiple imputation in a large-scale complex survey: a practical guide. Stat Methods Med Res 2010;19:653-70.
18. Forsberg JA, Eberhardt J, Boland PJ, et al. Estimating survival in patients with operable skeletal metastases: an application of a Bayesian Belief Network. PLoS One 2011;6:e19956.
19. Stojadinovic A, Nissan A, Eberhardt J, et al. Development of a Bayesian Belief Network model for personalized prognostic risk assessment in colon carcinomatosis. Am Surg 2011;77:221-30.
20. Stojadinovic A, Eberhardt C, Henry L, et al. Development of a Bayesian Classifier for Breast Cancer Risk Stratification: A Feasibility Study. ePlasty Open Access Journal, Volume 10, March 29, 2010. Available at: http://www.eplasty.com/index.php?option=com-content&view=article&id=433&catid=171:volume-10-eplasty-2010&Itemid=121. Accessed February 21, 2014.
21. Kahn KL, Adams JL, Weeks JC, et al. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA 2010;303:1037-45.
22. Sundararajan V, Mitra N, Jacobson JS, et al. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 2002;136:349-57.
23. Zuckerman IH, Rapp T, Onukwugha E, et al. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. J Am Geriatr Soc 2009;57:1403-10.
24. Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol 2007;14:2759-65.
25. Paulson EC, Mahmoud NN, Wirtalla C, et al. Acuity and survival in colon cancer surgery. Dis Colon Rectum 2010;53:385-92.
26. Steele SR, Chen SL, Stojadinovic A, et al. The impact of age on quality measure adherence in colon cancer. J Am Coll Surg 2011;213:95-103; discussion 104-5.
27. Earle CC, Weiser MR, Ter Veer A, et al. Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol 2009;100:525-8.
28. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001;93:850-7.
29. Hsiao FY, Mullins CD, Onukwugha E, et al. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with Stage III colon cancer: a 'real world' analysis using Surveillance, Epidemiology, and End Results-Medicare data. J Am Geriatr Soc 2011;59:1717-23.
30. Kirkpatrick HM, Aitelli CL, Qin H, et al. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer. Clin Colorectal Cancer 2010;9:150-6.
31. Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001;19:980-91.
32. Gribbin J, Dewis R. Adjuvant! Online: review of evidence concerning its validity, and other considerations relating to its use in the NHS; National Collaborating Centre for Cancer (UK). Early and Locally Advanced Breast Cancer: Diagnosis and Treatment [Internet]. Cardiff (UK): National Collaborating Centre for Cancer (UK); 2009 Feb. (NICE Clinical Guidelines, No. 80.). Available at: https://www.ncbi.nlm.nih.gov/books/NBK11639/. Accessed February 21, 2014.
33. Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 2008;26:380-5.